Spots Global Cancer Trial Database for Leukemic Phase of ALCL
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Leukemic Phase of ALCL
Official Title: Leukemic Phase of ALK+ Anaplastic Lymphoma in Real-life Practice: Experience of a University Clinical Hematology Laboratory
Study ID: NCT04908059
Conditions
Interventions
Study Description
Brief Summary: Collecting data about the rare leukemic presentation of anaplastic lymphoma to study the characteristics of patients with leukemic phase of ALCL
Detailed Description:
Eligibility
Minimum Age: 9 Years
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hematology Laboratory - Strasbourg University Hospitals, Strasbourg, , France
Contact Details
Name: Laurent MAUVIEUX, MD, PhD
Affiliation: Hematology Laboratory - Strasbourg University Hospitals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
